Objective:

To identify early molecular changes in knee joints associated with osteoarthritis (OA) progression, which could lead to improved diagnostic and therapeutic strategies.

Key Findings:

• Strong upregulation of collagen-derived peptides and post-translational modifications linked to matrix stiffening in subchondral bone beneath damaged cartilage, indicating early disease processes.
• Bone remodeling indicators were found even beneath structurally intact cartilage, suggesting early disease signals that could inform diagnosis.
• Bone-associated protein fragments identified in tissue were also detected in synovial fluid from OA patients, while cartilage markers were reduced, highlighting the potential for fluid-based biomarkers.

Interpretation:

Subchondral bone may serve as an early indicator of osteoarthritis progression, with potential for developing fluid-based tests to assess joint remodeling and improve patient management.

Limitations:

• Study focused on end-stage OA patients, which may limit generalizability to earlier stages of the disease.
• Further validation needed to establish clinical applicability of identified biomarkers across diverse patient demographics.

Conclusion:

Tracking bone-specific molecular changes could facilitate earlier identification of at-risk patients and improve monitoring of therapeutic responses, ultimately enhancing patient outcomes.